Skip to main content
Caplight Logo









Daivergent

Daivergent

Private
New York City, New YorkHealthcare & Life Scienceshttps://daivergent.com

Last Round

VC Round

Jun 28, 2024

Total Funding Raised

$4.35M

Company Overview

Daivergent is a human capital services company that provides a job-readiness and care delivery platform for the adult disability population.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, HR

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting, Subscription SaaS, Freemium, Data as a Service

AI Layer

Non-AI

Keywords

neurodiversity hiringjob coachingvocational rehabilitationdisability employment servicesneurodivergent supportautism at workskills traininglife coachingdisability techMedicaid providerB2G platformdata annotation servicespublic benefit corporation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Daivergent Comparables

Compare Daivergent with similar companies based on industry and business-model similarity.

Daivergent comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AutonoMe
78%
CAI
72%
Specialisterne
72%

Daivergent Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 28, 2024
SeedAug 4, 2022
SeedJan 3, 2019
AcceleratorJun 11, 2018

Key People

Founding team and executive leadership

Byran Dai

Founder CEO

Founding Team

Daivergent Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 4, 2022

    $3.3M round led by Zeal Capital Partners.

  • Jan 3, 2019

    $950K raised from Kapor Capital and Western Technology Investment.

Daivergent Filings

Explore SEC and related filing metadata, where available.

Daivergent filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Daivergent's valuation, stock price, and market status.

Is Daivergent a public or private company?

Daivergent is a private company.

What is the current stock price of Daivergent?

Daivergent is a private company with no public stock price. No recent secondary market data is available.

How much is Daivergent worth (valuation)?

Valuation information for Daivergent is not publicly available.

Can I buy Daivergent stock?

Daivergent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Daivergent's last funding round?

Daivergent's most recent funding round was VC Round on June 28, 2024.

Who are the main investors in Daivergent?

Key investors in Daivergent include WGU Labs, Zeal Capital Partners.

Will Daivergent IPO soon?

No public IPO plans have been announced for Daivergent.

How can I track Daivergent secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Daivergent's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range93
Year Founded2017
Last FundingJun 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?